Cargando…

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer

OBJECTIVE: The Immunoscore method has proved fruitful for predicting prognosis in patients with colon cancer. However, there is still room for improvement in this scoring method to achieve further advances in its clinical translation. This study aimed to develop and validate a modified Immunoscore (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ke, Wu, Xiaomei, Li, Zhenhui, Wang, Yingyi, Xu, Zeyan, Li, Yajun, Wu, Lin, Yao, Su, Huang, Yanqi, Liang, Changhong, Liu, Zaiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286894/ https://www.ncbi.nlm.nih.gov/pubmed/34321834 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.09

Ejemplares similares

Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer
por: Zhao, Ke, et al.
Publicado: (2020)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
por: Xu, Zeyan, et al.
Publicado: (2021)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2020)

Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer
por: Huang, Yanqi, et al.
Publicado: (2022)

Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer
por: He, Lan, et al.
Publicado: (2022)

Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis
por: Zhao, Ke, et al.
Publicado: (2020)

Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021)

A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy
por: He, Lan, et al.
Publicado: (2021)

An immunoscore nomogram for predicting survival in patients with oesophageal cancer
por: Li, Gaoming, et al.
Publicado: (2021)

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
por: Wang, Fulong, et al.
Publicado: (2023)

Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer
por: Marliot, Florence, et al.
Publicado: (2020)

Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey
por: Kasi, Anup, et al.
Publicado: (2021)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

Biomarkers immune monitoring technology primer: Immunoscore® Colon
por: Hermitte, Fabienne
Publicado: (2016)

Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
por: Wirta, Erkki‐Ville, et al.
Publicado: (2017)

The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
por: Liang, Yanting, et al.
Publicado: (2021)

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2023)

Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
por: Guo, Congfang, et al.
Publicado: (2019)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification
por: Lin, Huan, et al.
Publicado: (2022)

Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer
por: Wu, Lei, et al.
Publicado: (2018)

Deep learning quantified mucus-tumor ratio predicting survival of patients with colorectal cancer using whole-slide images
por: Zhao, Ke, et al.
Publicado: (2021)

Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
por: Zhang, Fang, et al.
Publicado: (2020)

Artificial intelligence for quantifying immune infiltrates interacting with stroma in colorectal cancer
por: Yang, Jing, et al.
Publicado: (2022)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
por: Zhao, Zihuan, et al.
Publicado: (2020)

Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features
por: Yang, Xiaojun, et al.
Publicado: (2020)

The value of magnetic resonance imaging-based tumor shape features for assessing microsatellite instability status in endometrial cancer
por: Wang, Huihui, et al.
Publicado: (2022)

Multi-scale pathology image texture signature is a prognostic factor for resectable lung adenocarcinoma: a multi-center, retrospective study
por: Wang, Yumeng, et al.
Publicado: (2022)

Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer
por: He, Lan, et al.
Publicado: (2019)

Computerized tumor-infiltrating lymphocytes density score predicts survival of patients with resectable lung adenocarcinoma
por: Pan, Xipeng, et al.
Publicado: (2022)

Necrosis score as a prognostic factor in stage I–III colorectal cancer: a retrospective multicenter study
por: Ye, Huifen, et al.
Publicado: (2023)

Combining quantitative and qualitative magnetic resonance imaging features to differentiate anorectal malignant melanoma from low rectal cancer
por: Xu, Zeyan, et al.
Publicado: (2021)

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020)

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
por: Li, Yanyan, et al.
Publicado: (2020)

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
por: Wu, Zi-You, et al.
Publicado: (2020)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

The prognostic value of immunoscore in patients with colorectal cancer: A systematic review and meta‐analysis
por: Sun, Guorui, et al.
Publicado: (2018)

Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach
por: Feng, Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fg8o97nm7g0lhuclbinm2phnpq